Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 6.25 mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
Products
  • Carvedilol Tablets USP 6.25 mg
Where it was sold

U.S. Nationwide

Nationwide

Units affected
[100 Tablet Bottles] 90,000 bottles; [500 Tablet Bottles] 324,288 bottles
About this recall
Carvedilol Tablets USP 6.25 mg, a.)100-count bottle (NDC 68462-163-01), b.) 500-count bottle (NDC 68462-163-05) Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.